JO

Journal Of Clinical Tuberculosis And Other Mycobacterial Diseases

Journal of Clinical Tuberculosis and Other Mycobacterial Diseases is an Open Access publication that provides a forum for clinically relevant articles on all aspects of tuberculosis and other mycobacterial infections, including epidemiology, transmission, diagnosis, treatment, drug resistance, research, thematic reviews, and public policy.

Looking to publish in Journal Of Clinical Tuberculosis And Other Mycobacterial Diseases? Livewrite integrates seamlessly with Word to help you write, edit, and format faster.

Try Livewrite Now
Impact Factor 2
Quartile Q3
Open Access Type Open
ISSN 2405-5794
eISSN 2405-5794
Invitation Only No
Cost Range Article Publishing Charge (APC): USD 2,660 (excluding taxes).

Submission Instructions

Journal Of Clinical Tuberculosis And Other Mycobacterial Diseases accepts the following article types. Click on an article type to view submission instructions.

Original Research Article

Cover Letter Cover Letter requirements are not specified.
Abstract An abstract is required. Abstract must not exceed 250 words. Abstract must be unstructured and concise and factual.
Manuscript Manuscript must not exceed 3000 words. Manuscript should be divided into clearly defined and numbered sections. Manuscript must include 1 to 7 keywords, and highlights of 3 to 5 bullet points must be submitted as a separate editable file, and any generative AI use in manuscript preparation must be declared in a section before the references list.
References References are limited to a maximum of 40. References must be cited as numbers in square brackets. References must be numbered in the order of appearance in the text, include standard bibliographic details, use abbreviated journal names, and list the first 6 authors followed by 'et al.' when there are more than 6 authors.
Figures & Tables A maximum of 5 tables and figures is allowed. Figures must be uploaded as separate files, while tables must be submitted as editable text. Tables must include captions and be cited in the text, and figures must be numbered in sequence, cited in the text, and accompanied by captions.
Reformat to Journal Of Clinical Tuberculosis And Other Mycobacterial Diseases using Livewrite Premium

Review

Cover Letter Cover Letter requirements are not specified.
Abstract Abstract is required. Abstract must not exceed 250 words. Abstract must be unstructured and concise and factual.
Manuscript Review manuscripts must not exceed 4,000 words. Articles should be divided into clearly defined and numbered sections. Manuscripts must include 1 to 7 English keywords, 3 to 5 highlights submitted as a separate editable file, declarations completed for competing interests, and an AI-use declaration placed in a new section before the references if generative AI was used in manuscript preparation.
References Reviews may include up to 70 references. References must be cited as numbers in square brackets, listed in the reference list in order of appearance, and for works with more than 6 authors the first 6 should be listed followed by 'et al.'.
Figures & Tables Reviews may include a maximum of 5 tables and figures. Figures must be supplied as separate files, while tables must be submitted as editable text. All figures and tables must be cited in the text, numbered consecutively in order of appearance, and include captions.
Reformat to Journal Of Clinical Tuberculosis And Other Mycobacterial Diseases using Livewrite Premium

Letter To The Editor

Cover Letter Cover Letter requirements are not specified.
Abstract Abstract must not exceed 250 words.
Manuscript Letter to the Editor must not exceed 1,000 words. Article should be divided into clearly defined and numbered sections. Manuscript must include 1 to 7 keywords in English, submit 3 to 5 highlights as a separate editable file, include a declaration of generative AI use before the references if applicable, and place acknowledgements in a separate section directly before the references.
References Letter to the Editor may include up to 5 references. References must be cited as numbers in square brackets. Reference list must be numbered in the order of appearance in the text and list the first 6 authors followed by 'et al.' when there are more than 6 authors.
Figures & Tables Letter to the Editor may include a maximum of 1 table and figure. Figures must be uploaded as separate files, while tables must be submitted as editable text. Tables must be numbered consecutively and include captions, and figures must be numbered in text order and include captions.
Reformat to Journal Of Clinical Tuberculosis And Other Mycobacterial Diseases using Livewrite Premium

Case Report

Cover Letter Cover Letter requirements are not specified.
Abstract Abstract is required. Abstract must not exceed 250 words.
Manuscript Manuscript must not exceed 2,000 words. Case Reports must describe 1 or 3 patients or cases and place the individual case or case series in the context of a very robust discussion. Manuscript must include 1 to 7 keywords, and if generative AI was used in manuscript preparation a declaration statement must be included in a new section before the references list.
References References are limited to 25. References must be cited as numbers in square brackets and listed in the reference list in the order they appear in the text, with more than 6 authors shortened to the first 6 followed by 'et al.'.
Figures & Tables A maximum of 3 tables and figures may be included. Figures must be uploaded as separate files, while tables must be submitted as editable text. All figures and tables must be cited in the text, numbered consecutively in order of appearance, and include captions.
Reformat to Journal Of Clinical Tuberculosis And Other Mycobacterial Diseases using Livewrite Premium

Recent Publications

The critical link between clinical risk stratification and pharmacovigilance in tuberculosis therapy: implications for rifampicin-induced cholestatic jaundice

Preeti Lamba

10.1016/j.jctube.2026.100614
View Publication

Comment on “Prevalence and risk factors associated with rifampicin-induced cholestasis jaundice among tuberculosis patients in high-incidence setting: A retrospective cohort study”

Yuxia Yu

10.1016/j.jctube.2026.100615
View Publication

Efficacy and safety of an intravenous amikacin-containing regimen as initial therapy in Mycobacterium avium complex pulmonary disease

Tomoki Teramoto, Akihiro Ito, Yosuke Nakanishi, Toru Hashimoto, Tadashi Ishida

10.1016/j.jctube.2026.100621
View Publication

Illicit substance use and its impact on tuberculosis care engagement: A systematic review and Meta-analysis of prevalence

Alanna J. Bergman, Elizabeth Di Giacomo, Adam Leonard, Isabella Jung, Scott K. Heysell

10.1016/j.jctube.2026.100620
View Publication

Analysis of the differential clinical characteristics of tuberculosis and nontuberculous mycobacterial diseases among AIDS patients

Shuibao Xu, Junyang Yang, Jingna Xun, Renfang Zhang, Li Liu, Jun Chen, Zhenyan Wang, Tangkai Qi, Jianjun Sun, Wei Song, Yang Tang, Youming Chen, Yueming Shao, Xinyu Zhang, Zichen Song, Yinzhong Shen, Hongzhou Lu

10.1016/j.jctube.2026.100619
View Publication

Frequently asked questions

How long does it take to publish?

Proof corrections are requested within two days after proofs are sent.

Reformat to Journal Of Clinical Tuberculosis And Other Mycobacterial Diseases using Livewrite Premium

What are the publication costs?

Research Topics

Tuberculosis Research and Epidemiology Mycobacterium research and diagnosis Infectious Diseases and Tuberculosis Diagnosis and treatment of tuberculosis Pneumonia and Respiratory Infections Pneumocystis jirovecii pneumonia detection and treatment Infectious Diseases and Mycology Healthcare Systems and Reforms Global Maternal and Child Health COVID-19 diagnosis using AI COVID-19 Clinical Research Studies Immune responses and vaccinations HIV/AIDS Impact and Responses Child Nutrition and Water Access Bacterial Infections and Vaccines Antibiotic Use and Resistance Orthopedic Infections and Treatments Mobile Health and mHealth Applications Cancer therapeutics and mechanisms HIV/AIDS Research and Interventions COVID-19 epidemiological studies Ocular Diseases and Behçet’s Syndrome Tracheal and airway disorders Immunodeficiency and Autoimmune Disorders Leprosy Research and Treatment